Ocular Therapeutix, Inc. · 4 hours ago
Executive Director, ECP Marketing
Ocular Therapeutix, Inc. is a biopharmaceutical company focused on innovative therapies for eye diseases. The Executive Director of ECP Marketing will develop marketing strategies for retinal diseases, synthesizing insights to support patient treatment journeys and collaborating with internal and external stakeholders to optimize resources and tools.
BiotechnologyHealth CareMedical Device
Responsibilities
Design of the patient strategy and responsibility for associated educational support tools, platforms, and engagement. This includes ownership of patient associated budget, vendor management, KPI management and tracking for current and future products/indications
Oversee ECP insight collection, synthesis, and analysis to build and shape future strategies and support resources in partnership with strategic insights lead
Design a go to market engagement model for Retina Specialists and Practices from disease education through product availability and ongoing practice support
Engage with external customers and stakeholders to understand and capture emotional and physical journey through the Retina Specialists perspective to support development and build related tools and resources
Design, establish, and manage the reporting of ongoing performance analytics
Design, establish, and manage advanced analytics and insight capabilities to provide ongoing market feedback to leadership and the broader organization
Oversee overall KPIs and monitoring of ECP related marketing tools and resources
Oversee ECP budgeting and budget management
Monitor market insights to establish continuous improvement processes-consistently assessing and adjusting support provided to Retina Practices
Responsible for leading and executing in partnership with Commercial Operations, Marketing and Market Access Teams strategic direction and guidance on ECP related programs, platforms, and resources
Work closely with cross-functional stakeholders including Market Access, Commercial Operations, Brand Marketing, Sales, Legal, and Medical, along with relevant external customers
Achieve brand-specific marketing objectives and KPIs at launch and throughout the products’ lifecycle
Support the marketing team with effective communication to promptly identify and address ECP related issues and opportunities
Provide strategic insights and recommendations to develop compliant content for the company’s ECP education websites and drive material through review process as required
Serve as primary contact for field teams for ECP specific inquiries and coordinate issue resolution with appropriate stakeholders
Qualification
Required
Requires a BA or BS degree (advanced degree preferred)
Minimum 5 years directly managing ECP related programs and resources
Minimum 8 years of experience working with ECPs (i.e., Retina Specialists)
Minimum 10+ years of other related pharma/biotech experience strongly preferred (e.g., Product Marketing)
Prior experience launching buy-an-bill drugs in ophthalmology / retina preferred
Ability to lead without authority within cross-functional groups and in a matrix organization
Exceptional professional communications and interpersonal/critical thinking skills necessary to interact with key decision makers (CEO, Sr. VP Commercial and other c-suite level stakeholders)
Demonstrated ability to identify key access barriers and design effective resolution plans
Analytical Thinker – someone who can sort through complex data and assimilate data sets to help inform major decisions
Project Management Expert – someone who can manage multiple workstreams to ensure that deadlines are met when there are multiple different ongoing projects
Ensures compliance with all corporate and industry policies in collaboration with Legal, Regulatory and Compliance Qualifications
Desire to innovate and work in a fast-paced, energetic environment
Requires up to 25% domestic travel
Company
Ocular Therapeutix, Inc.
Ocular Therapeutix, Inc. is a biopharmaceutical company committed to redefining the retina experience across drug development, treatment, and outcomes.
Funding
Current Stage
Public CompanyTotal Funding
$1.19BKey Investors
Ascension VenturesPolaris Partners
2025-09-30Post Ipo Equity· $475M
2024-02-22Post Ipo Equity· $325M
2023-12-13Post Ipo Equity· $115.11M
Leadership Team
Recent News
2026-01-24
2026-01-23
2026-01-23
Company data provided by crunchbase